Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

7 Citations (Scopus)

Abstract

Introduction: Traditionally, Nottingham prognostic index (NPI) informed prognosis in patients with estrogen receptor positive, human epidermal growth factor receptor-2 negative, node negative (ER+/HER2-/LN-) breast cancer.

Original languageEnglish
Pages (from-to)227-235
Number of pages9
JournalBreast
Volume66
DOIs
Publication statusPublished - Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Breast cancer
  • Cancer surgery
  • Oncological outcomes
  • Surgical oncology

Fingerprint

Dive into the research topics of 'Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer'. Together they form a unique fingerprint.

Cite this